EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
45 hedge funds and large institutions have $66.2M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
45
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$118K | |
| 3 | +$61.7K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$36.8K |
| 5 |
State Street
Boston,
Massachusetts
|
+$28.9K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$802K | |
| 3 | -$367K | |
| 4 |
Morgan Stanley
New York
|
-$76.1K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$65K |